Polaris Market Research has published its latest research report titled Prostate Cancer Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies); By Region; Segment Forecast, 2026 - 2034. The report...
Polaris Market Research has published its latest research report titled Prostate Cancer Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies); By Region; Segment Forecast, 2026 - 2034. The report...
The Nuclear Medicine Radiopharmaceuticals Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred.
Management should view the market as a...
Global Nuclear Medicine Market Set for Transformational Expansion as Precision Oncology, Theranostics, and Advanced Radioisotopes Reshape Modern Clinical Interventions
The global nuclear medicine landscape is undergoing an unprecedented paradigm shift, evolving from a supplementary diagnostic modality into a central pillar of personalized, targeted therapeutics. Historically leveraged...
Clinical Precision and Targeted Theranostics: Global Nuclear Medicine Market Set to Reach USD 18.87 Billion by 2030
Maximize Market Research, a global market intelligence, sector forecasting, and executive consulting powerhouse, has published a comprehensive industry analysis of the Global Nuclear Medicine Market. Valued at USD 7.22 Billion in 2023, the global nuclear medicine sector is on an...
The Global PET Nuclear Medicine Market is experiencing significant growth due to increasing demand for advanced diagnostic imaging, rising cancer prevalence, and the expanding use of positron emission tomography (PET) in disease detection and treatment monitoring. PET nuclear medicine uses radiopharmaceuticals, also known as radiotracers, to visualize metabolic and biological processes within...
polaris Market Research today announced findings from its latest report, projecting the global Ethylene Oxide Sterilization Services market to grow from USD 4,595.46 million in 2023 to USD 11,168.31 million by 2032, at a CAGR of 10.4%. The report profiles 8 leading companies across four market segments.
Analyst Commentary on Ethylene Oxide Sterilization Services Market Growth
“Ethylene...
The global connected rail market was valued at USD 93,831.91 million in 2022 and is projected to reach USD 192,482.92 million by 2032, expanding at a CAGR of 5.9% from 2023 to 2032. These findings come from the latest Polaris Market Research study, Connected Rail Market , which evaluates the factors shaping demand, the segments and regions expected to contribute most to growth, and the...
Cell-based medicine is moving from experimental clinics to commercial-scale production, and the manufacturing backbone behind it is straining to keep pace. According to Polaris Market Research, the global cell therapy manufacturing market was valued at USD 5.68 Billion in 2024 and is projected to reach USD 24.18 Billion by 2034, growing at a CAGR of 15.6%.
The Shift: What's Actually Changing...
Polaris Market Research presents its latest market research report, titled Antiparasitic Drugs Market Size, Share, Global Analysis Report, 2025-2034. It is a comprehensive market research report analyzing the fast-evolving antiparasitic drugs market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope...
According to the latest report published by Data Bridge Market Research, the Radiopharmaceutical CDMO Market
The Radiopharmaceutical CDMO Market was valued at USD 2.18 billion in 2025 and is projected to reach USD 6.26 billion by 2033, growing at a CAGR of 14.10% from 2026 to 2033.
Market research analysis and data in this Radiopharmaceutical CDMO Market document promisingly...
According to a new report by Polaris Market Research, the global coagulation analyzer market was valued at USD 4.42 billion in 2025 and is projected to reach USD 6.81 billion by 2034, expanding at a CAGR of 4.9% over the forecast period. Growth is underpinned by rising prevalence of blood-clotting disorders, expanding cardiovascular disease burden, and accelerating adoption of...